Polycystic Kidney Disease Proteins Share Common Pathway
Mutationsin PKHD1, the gene encoding fibrocystin/polyductin (FPC), causeautosomal recessive polycystic kidney disease (ARPKD). Kim etal. generated Pkhd1-deficient mice, which recapitulated theARPKD phenotype, to test the hypothesis that FPC and polycystin-2,the gene product of PKD2, which is altered in some cases ofautosomal dominant kidney disease, function in a common pathway.They report that FPC and polycystin-2 physically interact andthat the former regulates expression of the latter. In addition,the ion channel function of polycystin-2 is abnormal in theabsence of FPC, further supporting a functional link betweenthese two proteins. See Kim et al., pages 455–468.
T-bet Promotes Renal Injury in Crescentic GN
Crescenticglomerulonephritis is driven by an immune response consistingpredominantly of the Th1 subset of helper T cells. T-bet isa transcription factor that plays a role in committing CD4+T cells to the Th1 lineage. Phoon et al. report that, upon inductionof glomerulonephritis in mice, T-bet–/– mice developfewer glomerular crescents, less proteinuria, and less tubulointerstitialinflammation than wild-type mice. They observed decreased intrarenallevels of chemoattractants of Th1 cells and reduced Th1 systemicimmunity. These results suggest that T-bet may promote renalinjury in crescentic glomerulonephritis by altering the Th1/Th2balance of the immune response. See Phoon et al., pages 477–485.
Podocytes Form Glomerular Crescents
Do humanglomerular crescents contain podocytes? This has been a difficultquestion to answer, because injured podocytes lose their differentiationmarkers, making their identification challenging. Thorner etal. hypothesized that nestin, an intermediate filament proteinthat is detected in both normal and diseased podocytes, couldbe used to determine whether podocytes participate in the formationof crescents. The authors studied 35 human biopsies showingcrescentic glomerulonephritis and found that all crescents containednestin-positive cells, and many of these cells were proliferating.Two mouse models of glomerulonephritis support their conclusionthat podocytes play a role in the formation of glomerular crescents.See Thorner et al., pages 495–502.
Intensive Insulin Therapy Benefits Kidneys in Critically Ill
Two large,randomized, controlled trials have shown that intensive insulintherapy benefits the kidney function of critically ill patients.Schetz et al. combined the data from 2707 patients in thesetrials and performed a secondary analysis of the renoprotectiveeffects of insulin. The benefits of intensive insulin therapyare most pronounced in surgical patients, for whom it reducesthe risk for a composite acute kidney injury end point as wellas for individual end points of oliguria and need for renalreplacement therapy. Patients in the medical intensive careunit experience less benefit, but their greater severity ofillness on admission may explain this difference. See Schetzet al., pages 571–578.
Coronary Artery Calcification in Mild to Moderate CKD
Among peoplewith ESRD, coronary artery calcification is extremely common.It is unknown, however, whether less severe kidney dysfunctionis also associated with increased vascular calcification. Ixet al. evaluated 6749 middle-aged participants without cardiovasculardisease in the Multi-Ethnic Study of Atherosclerosis. Theirunadjusted analysis suggests an association of kidney dysfunctionand coronary artery calcification, but this association is completelylost after adjustment for age, gender, race, hypertension, andIL-6 levels. These results suggest that accelerated coronaryartery calcification is unlikely to explain the increased cardiovascularrisk among those with mild to moderate kidney dysfunction. SeeIx et al., pages 579–585.
ChromograninA, released from vesicles of neuronal cells along with catecholamines,plays a role in determining sympathetic tone. Salem et al. performedtwo independent case-control studies to investigate variantsin the chromogranin A gene (CHGA) among black individuals. Theauthors report that two specific CHGA haplotypes were significantlymore common in those with hypertensive ESRD than in disease-freecontrol subjects, and they explore the possible functional relevanceof these variants. Their findings are consistent with the hypothesisthat altered sympathetic tone contributes to the pathogenesisof hypertensive nephrosclerosis in black individuals. See Salemet al., pages 600–614.
Related Articles
Tight Blood Glucose Control Is Renoprotective in Critically Ill Patients
Miet Schetz, Ilse Vanhorebeek, Pieter J. Wouters, Alexander Wilmer, and Greet Van den Berghe
J. Am. Soc. Nephrol. 2008 19: 571-578.
[Abstract][Full Text][PDF]
Podocytes Contribute to the Formation of Glomerular Crescents
Paul S. Thorner, Michael Ho, Vera Eremina, Yoshikazu Sado, and Susan Quaggin
J. Am. Soc. Nephrol. 2008 19: 495-502.
[Abstract][Full Text][PDF]
T-bet Deficiency Attenuates Renal Injury in Experimental Crescentic Glomerulonephritis
Richard K. S. Phoon, A. Richard Kitching, Dragana Odobasic, Lynelle K. Jones, Timothy J. Semple, and Stephen R. Holdsworth
J. Am. Soc. Nephrol. 2008 19: 477-485.
[Abstract][Full Text][PDF]
Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease
Rany M. Salem, Peter E. Cadman, Yuqing Chen, Fangwen Rao, Gen Wen, Bruce A. Hamilton, Brinda K. Rana, Douglas W. Smith, Mats Stridsberg, Harry J. Ward, Manjula Mahata, Sushil K. Mahata, Donald W. Bowden, Pamela J. Hicks, Barry I. Freedman, Nicholas J. Schork, and Daniel T. O'Connor
J. Am. Soc. Nephrol. 2008 19: 600-614.
[Abstract][Full Text][PDF]
Association of Mild to Moderate Kidney Dysfunction and Coronary Calcification
Joachim H. Ix, Ronit Katz, Bryan Kestenbaum, Linda F. Fried, Holly Kramer, Catherine Stehman-Breen, and Michael G. Shlipak
J. Am. Soc. Nephrol. 2008 19: 579-585.
[Abstract][Full Text][PDF]
Fibrocystin/Polyductin Modulates Renal Tubular Formation by Regulating Polycystin-2 Expression and Function
Ingyu Kim, Yulong Fu, Kwokyin Hui, Gilbert Moeckel, Weiyi Mai, Cunxi Li, Dan Liang, Ping Zhao, Jie Ma, Xing-Zhen Chen, Alfred L. George, Jr., Robert J. Coffey, Zhong-Ping Feng, and Guanqing Wu
J. Am. Soc. Nephrol. 2008 19: 455-468.
[Abstract][Full Text][PDF]